Zanubrutinib Monotherapy in Relapsed/Refractory Central Nervous System Lymphoma
Clinical trial NCT05117814 · UNKNOWN
Trial details
- NCT number
- NCT05117814
- Sponsor
- Peking University People's Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-01
- Primary completion
- 2023-01-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.